NCT02557971已完成不适用
Urinary Retention Rates in Clinical Practice After Treatment With OnabotulinumtoxinA for Idiopathic Overactive Bladder
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Allergan
- 入组人数
- 315
- 试验地点
- 7
- 主要终点
- Length of Time of Clean Intermittent Catheterization (CIC) Use
研究概览
简要总结
This study is a retrospective chart review of patients treated with BOTOX® for idiopathic Overactive Bladder (OAB) as standard of care in clinical practice. The study will determine the rate of post procedural urinary retention requiring catheterization and identify factors that may predict urinary retention.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients treated with BOTOX® for Overactive Bladder.
排除标准
- •Received botulinum toxin formulations other than BOTOX® in the bladder.
- •Had symptoms of OAB associated with a neurological condition.
- •Had a history of chronic urinary retention treated with Clean Intermittent Catheterization (CIC) or indwelling catheter.
研究组 & 干预措施
BOTOX®
Patients with idiopathic overactive bladder (OAB) treated with onabotulinumtoxinA (BOTOX®) injections into the bladder as standard of care in clinical practice. No intervention was administered in this study.
干预措施: onabotulinumtoxinA (Drug)
结局指标
主要结局
Length of Time of Clean Intermittent Catheterization (CIC) Use
时间窗: 12 Weeks
Percentage of Participants with Post-Procedure Urinary Retention requiring Catheterization
时间窗: 12 Weeks
次要结局
- Percentage of Participants with Urinary Tract Infection (UTI)(12 Weeks)
研究者
研究点 (7)
Loading locations...
相似试验
Unknown
不适用
Use of Repris Needle in Bladder InjectionOveractive Bladder SyndromeNCT04982120Uro-1 Medical40
Enrolling By Invitation
不适用
Evaluation of Efficacy and Patient Satisfaction of Local Anaesthesia Versus Sedoanalgesia for Botox (R) Injection in the Urinary Bladder for the Treatment of Idiopathic Overactive BladderOveractive BladderNCT06437899Hospital LKH Hochsteiermark - Leoben84
Unknown
4 期
Botulinum Toxin in the Treatment of Idiopathic Detrusor OveractivityOveractive DetrusorNCT02009540Mr HD Flood60
Unknown
4 期
BOTOX® at the Time of Prolapse Surgery for OABUrinary Bladder, OveractivePelvic Organ ProlapseNCT04807920Walter Reed National Military Medical Center138
已完成
不适用
Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC)Urinary Bladder, OveractiveNCT03043287Allergan420